<DOC>
	<DOCNO>NCT01932034</DOCNO>
	<brief_summary>We compare percentage patient therapeutic vancomycin serum concentration current standard dosing , dose software . We also include therapeutic outcome cost analysis .</brief_summary>
	<brief_title>Prospective Study Optimize Vancomycin Dosing Children Adults Using Computer Software</brief_title>
	<detailed_description>Recent guideline use antibiotic vancomycin serious , resistant gram-positive bacterial infection advocate high plasma concentration routinely achieve conventional dosing . Moreover , wide interpatient variability vancomycin plasma concentration , even standardize dosing . The hypothesis study dose vancomycin assist computer software Bayesian algorithms lead rapid accurate attainment therapeutic blood vancomycin concentration child adult . This study enroll 90 patient per year three year , total 270 patient . Eligible patient age prescribe vancomycin clinician medical indication . Patients vancomycin-resistant organism , severe vancomycin allergy need dialysis eligible . Participants first group 90 treat accord standard care . The second third group patient dose vancomycin accord recommendation make study team use BestDose software develop USC Laboratory Applied Pharmacokinetics . The second group dose software current form , third group fund update . For group , additional blood sample draw research purpose ; routinely obtain clinical data use . The primary outcome group percentage participant appropriate vancomycin concentration . Secondary outcome receive vancomycin least 72 hour include effectiveness , toxicity rate , cost therapy . Participation study cease time hospital discharge 72 hour termination vancomycin therapy .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>1 . Hospitalized infant , child , adolescent , adult require , start vancomycin therapy infection suspect proven betalactam resistant grampositive bacteria eligible enrollment . 2 . Participants age . 3 . Participant/parent/legal guardian ( applicable ) must able willing provide sign informed consent . 1 . Prior receipt vancomycin clinical event ( e.g . fever unknown origin neutropenic patient define &lt; 24 hour fever ) 2 . Known colonization infection vancomycin resistant organism ( MIC &gt; 2 mg/L ) 3 . Known hypersensitivity intolerance vancomycin 4 . Patients form dialysis 5 . Not expect survive &gt; 72 hour .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Vancomycin</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Decision support</keyword>
</DOC>